Table 2 Prevalence of AMR and ESBL (phenotype and genotype) among phylogenetic groups of 72 APEC isolates (n; % within each phylogroup)
Phylogroup (n) | Phenotypic AMR | β-Lactamase/ESBL | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SXT | TET | ENFX | FLO | NEO | FDZ | GEN | AMC | CFZ | MDR | Phenotype | blaTEM | blaCTX | blaOXA | |
A (11) | 10 (90.9) | 9 (81.81) | 10 (90.9) | 8 (72.72) | 7 (63.63) | 2 (18.18) | 1 (9.09) | 1 (9.09) | 0 | 10 (90.9) | 1 (9.09) | 8 (72.72) | 1 (9.09) | 0 |
B1 (9) | 9 (100) | 9 (100) | 8 (88.88) | 3 (33.33) | 3 (33.33) | 5 (55.55) | 1 (11.11) | 1 (11.11) | 0 | 8 (88.88) | 1 (11.11) | 4 (44.44) | 1 (11.11) | 0 |
B2 (4) | 3 (75) | 4 (100) | 2 (50) | 3 (75) | 3 (75) | 1 (25) | 0 | 0 | 0 | 4 (100) | 0 | 1 (25) | 0 | 0 |
C (10) | 9 (90) | 8 (80) | 9 (90) | 9P(90) | 10P(100) | 4 (40) | 4P(40) | 0 | 0 | 9 (90) | 4 (40) | 8 (80) | 1 (10) | 0 |
D (17) | 15 (88.23) | 14 (82.35) | 15 (88.23) | 9 (52.94) | 5 (29.41) | 4 (23.52) | 1 (5.88) | 3 (17.64) | 2 (11.76) | 14 (82.35) | 10P(58.82) | 12 (70.58) | 13P(76.47) | 0 |
E (10) | 9 (90) | 10 (100) | 8 (80) | 5 (50) | 3 (30) | 2 (20) | 2 (20) | 3 (30) | 0 | 10 (100) | 4 (40) | 7 (70) | 3 (30) | 1 (10) |
F (11) | 8 (72.72) | 9 (81.81) | 7 (63.63) | 4 (36.36) | 4 (36.36) | 5 (45.45) | 1 (9.09) | 2 (18.18) | 1 (9.09) | 8 (72.72) | 4 (36.36) | 4 (36.36) | 4 (36.36) | 0 |
Total (72) | 63 (87.5) | 63 (87.5) | 59 (81.9) | 41 (56.9) | 35 (48.6) | 23 (31.94) | 10 (13.9) | 10 (13.9) | 3 (4.2) | 63 (87.5) | 24 (33.33) | 44 (61.11) | 23 (31.94) | 1 (1.38) |
p-value | 0.637 | 0.562 | 0.315 | 0.110 | 0.006 | 0.447 | 0.234 | 0.535 | 0.539 | 0.570 | 0.055 | 0.164 | 0.000 | 0.392 |